165 related articles for article (PubMed ID: 8051830)
1. [GLP-1 and the control of insulin secretion].
Thorens B
Journ Annu Diabetol Hotel Dieu; 1994; ():33-46. PubMed ID: 8051830
[No Abstract] [Full Text] [Related]
2. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
Gefel D; Barg Y; Zimlichman R
Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
[TBL] [Abstract][Full Text] [Related]
3. The glucagon-like peptides: a double-edged therapeutic sword?
Perry T; Greig NH
Trends Pharmacol Sci; 2003 Jul; 24(7):377-83. PubMed ID: 12871671
[No Abstract] [Full Text] [Related]
4. [GIP and GLP-1: multiplicity of regulator mechanisms for insulin secretion].
Thorens B
Journ Annu Diabetol Hotel Dieu; 2004; ():111-25. PubMed ID: 15259310
[No Abstract] [Full Text] [Related]
5. [Role of glucagon-like peptide 1 (GLP-1) in regulation of insulin secretion].
Radosavljević T; Todorović V; Sikić B
Srp Arh Celok Lek; 2002; 130(11-12):416-9. PubMed ID: 12751170
[No Abstract] [Full Text] [Related]
6. Glucagon-like peptide-1 and control of insulin secretion.
Thorens B
Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147
[TBL] [Abstract][Full Text] [Related]
7. Is glucagon-like peptide 1 an incretin hormone?
Nauck MA
Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM.
Thorens B; Waeber G
Diabetes; 1993 Sep; 42(9):1219-25. PubMed ID: 8349031
[TBL] [Abstract][Full Text] [Related]
9. [Glucagon-like peptide-1 (GLP-1) receptor].
Taminato T
Nihon Rinsho; 2002 Jul; 60 Suppl 7():535-41. PubMed ID: 12238094
[No Abstract] [Full Text] [Related]
10. Incretins, insulin secretion and Type 2 diabetes mellitus.
Vilsbøll T; Holst JJ
Diabetologia; 2004 Mar; 47(3):357-366. PubMed ID: 14968296
[TBL] [Abstract][Full Text] [Related]
11. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide.
Fehmann HC; Göke R; Göke B
Endocr Rev; 1995 Jun; 16(3):390-410. PubMed ID: 7671853
[No Abstract] [Full Text] [Related]
12. Overview of incretin hormones.
Efendic S; Portwood N
Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptides.
Drucker DJ
Diabetes; 1998 Feb; 47(2):159-69. PubMed ID: 9519708
[TBL] [Abstract][Full Text] [Related]
14. GLP-1 in NIDDM.
Holst JJ
Diabet Med; 1996 Sep; 13(9 Suppl 6):S156-60. PubMed ID: 8894501
[TBL] [Abstract][Full Text] [Related]
15. Incretin hormones and insulin secretion.
Ahrén B; Gromada J; Schmitz O
Horm Metab Res; 2004; 36(11-12):733-4. PubMed ID: 15655700
[No Abstract] [Full Text] [Related]
16. GLP-1 and the gut.
Thompson DG
Gut; 2000 May; 46(5):591. PubMed ID: 10764696
[No Abstract] [Full Text] [Related]
17. ["Glucagon-like peptide I": a therapeutic alternative for diabetes mellitus?].
Fehmann HC; Göke B
Dtsch Med Wochenschr; 1994 Feb; 119(8):275-9. PubMed ID: 8112212
[No Abstract] [Full Text] [Related]
18. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1. Gastrointestinal function and possible mechanism of action.
Wettergren A
Dan Med Bull; 2001 Feb; 48(1):19-28. PubMed ID: 11258148
[No Abstract] [Full Text] [Related]
20. Gastro-intestinal hormones GIP and GLP-1.
Kieffer TJ
Ann Endocrinol (Paris); 2004 Feb; 65(1):13-21. PubMed ID: 15122087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
